Positron Corp. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2010
2011
2012
2013
2014
Net Income before Extraordinaries
10,923.00
6,121.00
7,955.00
7,104.00
2,584.00
Depreciation, Depletion & Amortization
43.00
77.00
303.00
160.00
152.00
Other Funds
531.00
-
20.00
2,245.00
435.00
Funds from Operations
4,484.00
3,871.00
2,340.00
2,664.00
1,674.00
Changes in Working Capital
203.00
204.00
100.00
382.00
741.00
Net Operating Cash Flow
4,687.00
4,075.00
2,240.00
3,046.00
2,415.00
Capital Expenditures
238.00
10.00
73.00
16.00
26.00
Sale of Fixed Assets & Businesses
-
-
1.00
-
-
Net Investing Cash Flow
238.00
10.00
72.00
16.00
26.00
Issuance/Reduction of Debt, Net
1,000.00
2,100.00
2,191.00
2,318.00
340.00
Net Financing Cash Flow
5,916.00
2,945.00
2,554.00
4,563.00
905.00
Net Change in Cash
976.00
1,140.00
242.00
1,501.00
1,536.00
Free Cash Flow
4,925.00
4,085.00
2,313.00
3,062.00
2,441.00
Change in Capital Stock
7,447.00
845.00
383.00
-
1,000.00
Exchange Rate Effect
15.00
-
-
-
-

About Positron

View Profile
Address
1777 Maryland Avenue
Niagara Falls New York 14305
United States
Employees -
Website http://www.positron.com
Updated 07/08/2019
Positron Corp. is a nuclear medicine healthcare company specializing in the field of cardiac positron emission tomography imaging. It provides an economical, end-to-end solution for PET myocardial perfusion imaging through complementary product integration of PET imaging systems, radiopharmaceuticals and radioisotopes. The company was founded by Roman Oliynyk on December 20, 1983 and is headquartered in Westmont, IL.